We’re pleased to be joining the Neonatal and Paediatric Pharmacy Group’s 30th annual conference, 8–11 November.
Our CEO, Nicholas Appelbaum, and Implementation and Evaluation Lead, Calandra Feather, will host a roundtable to discuss how to improve prescribing safety in hospitals.
Roundtable details
Date: 8 November 2024, 19:15
Where: Room 2
Drawing from our West London Children’s Healthcare implementation, reaching half a million children, and our recent research led by Imperial College London researchers, the team will share how prescribing errors can be reduced by more than 80% compared with existing clinical practice. [1]
If you’re at the event, please do join the roundtable, or stop by our stand to talk.
Sources
Feather C, Clarke J, Appelbaum N, Darzi A, Franklin BD. Comparing safety, performance and user perceptions of a patient-specific indication-based prescribing tool with current practice: a mixed methods randomised user testing study. BMJ Quality & Safety. 2025;34(11):737–746.
doi:10.1136/bmjqs-2024-017733PMID 39577867
